Pathstone Holdings
ALNY icon

Pathstone Holdings’s Alnylam Pharmaceuticals ALNY Stock Holding History

Pathstone Holdings’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.34M Buy
7,072
+933
+15% +$317K 0.01% 949
2025
Q4 		$2.44M Sell
6,139
-158
-3% -$69.9K 0.01% 918
2025
Q3 		$2.87M Buy
6,297
+221
+4% +$90K 0.01% 832
2025
Q2 		$1.98M Sell
6,076
-222
-4% -$61.4K 0.01% 1003
2025
Q1 		$1.7M Buy
6,298
+115
+2% +$29.6K 0.01% 1071
2024
Q4 		$1.45M Sell
6,183
-66
-1% -$17.4K 0.01% 1158
2024
Q3 		$1.72M Buy
6,249
+629
+11% +$164K 0.01% 1069
2024
Q2 		$1.37M Buy
5,620
+1,762
+46% +$278K 0.01% 1127
2024
Q1 		$577K Buy
3,858
+974
+34% +$162K ﹤0.01% 1615
2023
Q4 		$552K Buy
+2,884
New +$491K ﹤0.01% 1439

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return